Jim Simons Exelixis, Inc. Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Exelixis, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 15,819,765 shares of EXEL stock, worth $594 Million. This represents 0.99% of its overall portfolio holdings.
Number of Shares
15,819,765
Previous 14,824,265
6.72%
Holding current value
$594 Million
Previous $547 Million
27.41%
% of portfolio
0.99%
Previous 0.88%
Shares
27 transactions
Others Institutions Holding EXEL
# of Institutions
674Shares Held
262MCall Options Held
1.58MPut Options Held
1.17M-
Black Rock Inc. New York, NY33.5MShares$1.26 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA27.5MShares$1.03 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA22.5MShares$845 Million4.78% of portfolio
-
State Street Corp Boston, MA11.8MShares$442 Million0.02% of portfolio
-
Lsv Asset Management Chicago, IL7.82MShares$293 Million0.82% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $12.1B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...